Search research articles
Contact Us
Filters
Showing results (101-110 of 163) with videos related to
Page
of 17
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica
|
February 22, 2017
Case mix adjusted variation in cesarean section rate in Sweden
Johan Mesterton, Lars Ladfors, Anna Ekenberg Abreu, et al.
Clinical Cardiology
|
April 20, 2016
Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
Shravanthi R Gandra, Guillermo Villa, Gregg C Fonarow, et al.
Neurology
|
July 4, 2014
The burden of Duchenne muscular dystrophy: an international, cross-sectional study
Erik Landfeldt, Peter Lindgren, Christopher F Bell, et al.
American Journal of Obstetrics and Gynecology
|
September 22, 2009
Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions
Annika Idahl, Eva Lundin, Fredrik Elgh, et al.
Journal of Neuromuscular Diseases
|
February 13, 2016
Compliance to Care Guidelines for Duchenne Muscular Dystrophy
Erik Landfeldt, Peter Lindgren, Christopher F Bell, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
May 12, 2020
Second trimester cervical length measurements with transvaginal ultrasound: A prospective observational agreement and reliability study
Pihla Kuusela, Ulla-Britt Wennerholm, Helena Fadl, et al.
Diabetologia
|
September 24, 2020
Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden
Emelie Andersson, Sofie Persson, Nino Hallén, et al.
Neurology and Therapy
|
August 24, 2021
Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer's Disease
William L Herring, Ian Gopal Gould, Howard Fillit, et al.
Pharmacoeconomics
|
August 12, 2022
A Proposal of a Cost-Effectiveness Modeling Approach for Heart Failure Treatment Assessment: Considering the Short- and Long-Term Impact of Hospitalization on Event Rates
Gian Luca Di Tanna, Blake Angell, Michael Urbich, et al.
Diabetes, Obesity & Metabolism
|
April 25, 2020
Days absent from work as a result of complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden
Sofie Persson, Pierre Johansen, Emelie Andersson, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 163) with videos related to
Sort By:
Page
of 17
Acta Obstetricia Et Gynecologica Scandinavica
|
February 22, 2017
Case mix adjusted variation in cesarean section rate in Sweden
Johan Mesterton, Lars Ladfors, Anna Ekenberg Abreu, et al.
Clinical Cardiology
|
April 20, 2016
Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
Shravanthi R Gandra, Guillermo Villa, Gregg C Fonarow, et al.
Neurology
|
July 4, 2014
The burden of Duchenne muscular dystrophy: an international, cross-sectional study
Erik Landfeldt, Peter Lindgren, Christopher F Bell, et al.
American Journal of Obstetrics and Gynecology
|
September 22, 2009
Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions
Annika Idahl, Eva Lundin, Fredrik Elgh, et al.
Journal of Neuromuscular Diseases
|
February 13, 2016
Compliance to Care Guidelines for Duchenne Muscular Dystrophy
Erik Landfeldt, Peter Lindgren, Christopher F Bell, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
May 12, 2020
Second trimester cervical length measurements with transvaginal ultrasound: A prospective observational agreement and reliability study
Pihla Kuusela, Ulla-Britt Wennerholm, Helena Fadl, et al.
Diabetologia
|
September 24, 2020
Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden
Emelie Andersson, Sofie Persson, Nino Hallén, et al.
Neurology and Therapy
|
August 24, 2021
Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer's Disease
William L Herring, Ian Gopal Gould, Howard Fillit, et al.
Pharmacoeconomics
|
August 12, 2022
A Proposal of a Cost-Effectiveness Modeling Approach for Heart Failure Treatment Assessment: Considering the Short- and Long-Term Impact of Hospitalization on Event Rates
Gian Luca Di Tanna, Blake Angell, Michael Urbich, et al.
Diabetes, Obesity & Metabolism
|
April 25, 2020
Days absent from work as a result of complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden
Sofie Persson, Pierre Johansen, Emelie Andersson, et al.
Page
of 17